334 related articles for article (PubMed ID: 32615027)
1. Epidermal activation of Hedgehog signaling establishes an immunosuppressive microenvironment in basal cell carcinoma by modulating skin immunity.
Grund-Gröschke S; Ortner D; Szenes-Nagy AB; Zaborsky N; Weiss R; Neureiter D; Wipplinger M; Risch A; Hammerl P; Greil R; Sibilia M; Gratz IK; Stoitzner P; Aberger F
Mol Oncol; 2020 Sep; 14(9):1930-1946. PubMed ID: 32615027
[TBL] [Abstract][Full Text] [Related]
2. Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications.
Grund-Gröschke S; Stockmaier G; Aberger F
Cell Commun Signal; 2019 Dec; 17(1):172. PubMed ID: 31878932
[TBL] [Abstract][Full Text] [Related]
3. Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinoma.
Sternberg C; Gruber W; Eberl M; Tesanovic S; Stadler M; Elmer DP; Schlederer M; Grund S; Roos S; Wolff F; Kaur S; Mangelberger D; Lehrach H; Hache H; Wierling C; Laimer J; Lackner P; Wiederstein M; Kasper M; Risch A; Petzelbauer P; Moriggl R; Kenner L; Aberger F
Int J Cancer; 2018 Dec; 143(11):2943-2954. PubMed ID: 29987839
[TBL] [Abstract][Full Text] [Related]
4. Targeting class I histone deacetylases by the novel small molecule inhibitor 4SC-202 blocks oncogenic hedgehog-GLI signaling and overcomes smoothened inhibitor resistance.
Gruber W; Peer E; Elmer DP; Sternberg C; Tesanovic S; Del Burgo P; Coni S; Canettieri G; Neureiter D; Bartz R; Kohlhof H; Vitt D; Aberger F
Int J Cancer; 2018 Mar; 142(5):968-975. PubMed ID: 29055107
[TBL] [Abstract][Full Text] [Related]
5. DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
Gruber W; Hutzinger M; Elmer DP; Parigger T; Sternberg C; Cegielkowski L; Zaja M; Leban J; Michel S; Hamm S; Vitt D; Aberger F
Oncotarget; 2016 Feb; 7(6):7134-48. PubMed ID: 26784250
[TBL] [Abstract][Full Text] [Related]
6. Emerging Roles of Hedgehog Signaling in Cancer Immunity.
Giammona A; Crivaro E; Stecca B
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674836
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
Tanese K; Emoto K; Kubota N; Fukuma M; Sakamoto M
J Dermatol; 2018 Oct; 45(10):1181-1186. PubMed ID: 30035333
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of sonic hedgehog signaling-related molecules in basal cell carcinoma.
Kim HS; Kim YS; Lee C; Shin MS; Kim JW; Jang BG
PLoS One; 2019; 14(11):e0225511. PubMed ID: 31756206
[TBL] [Abstract][Full Text] [Related]
9. Cross-Talk between Wnt and Hh Signaling Pathways in the Pathology of Basal Cell Carcinoma.
Noubissi FK; Yedjou CG; Spiegelman VS; Tchounwou PB
Int J Environ Res Public Health; 2018 Jul; 15(7):. PubMed ID: 29987229
[TBL] [Abstract][Full Text] [Related]
10. A Novel Mechanism for Activation of GLI1 by Nuclear SMO That Escapes Anti-SMO Inhibitors.
Rahman MM; Hazan A; Selway JL; Herath DS; Harwood CA; Pirzado MS; Atkar R; Kelsell DP; Linton KJ; Philpott MP; Neill GW
Cancer Res; 2018 May; 78(10):2577-2588. PubMed ID: 29463581
[TBL] [Abstract][Full Text] [Related]
11. Genomic testing, tumor microenvironment and targeted therapy of Hedgehog-related human cancers.
Katoh M
Clin Sci (Lond); 2019 Apr; 133(8):953-970. PubMed ID: 31036756
[TBL] [Abstract][Full Text] [Related]
12. Targeting GLI Transcription Factors in Cancer.
Didiasova M; Schaefer L; Wygrecka M
Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137
[TBL] [Abstract][Full Text] [Related]
13. Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma.
Otsuka A; Dreier J; Cheng PF; Nägeli M; Lehmann H; Felderer L; Frew IJ; Matsushita S; Levesque MP; Dummer R
Clin Cancer Res; 2015 Mar; 21(6):1289-97. PubMed ID: 25593302
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Hedgehog signalling promotes pro-tumourigenic integrin expression and function.
Moutasim KA; Mellows T; Mellone M; Lopez MA; Tod J; Kiely PC; Sapienza K; Greco A; Neill GW; Violette S; Weinreb PH; Marshall JF; Ottensmeier CH; Sayan AE; Jenei V; Thomas GJ
J Pathol; 2014 Jun; 233(2):196-208. PubMed ID: 24573955
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase A activation inhibits oncogenic Sonic hedgehog signalling and suppresses basal cell carcinoma of the skin.
Makinodan E; Marneros AG
Exp Dermatol; 2012 Nov; 21(11):847-52. PubMed ID: 23163650
[TBL] [Abstract][Full Text] [Related]
16. Local immune response in cutaneous basal cell carcinoma.
Omland SH
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975891
[TBL] [Abstract][Full Text] [Related]
17. Antitumoral effects of calcitriol in basal cell carcinomas involve inhibition of hedgehog signaling and induction of vitamin D receptor signaling and differentiation.
Uhmann A; Niemann H; Lammering B; Henkel C; Hess I; Nitzki F; Fritsch A; Prüfer N; Rosenberger A; Dullin C; Schraepler A; Reifenberger J; Schweyer S; Pietsch T; Strutz F; Schulz-Schaeffer W; Hahn H
Mol Cancer Ther; 2011 Nov; 10(11):2179-88. PubMed ID: 21878656
[TBL] [Abstract][Full Text] [Related]
18. GLI activation by atypical protein kinase C ι/λ regulates the growth of basal cell carcinomas.
Atwood SX; Li M; Lee A; Tang JY; Oro AE
Nature; 2013 Feb; 494(7438):484-8. PubMed ID: 23446420
[TBL] [Abstract][Full Text] [Related]
19. Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells.
Eberl M; Klingler S; Mangelberger D; Loipetzberger A; Damhofer H; Zoidl K; Schnidar H; Hache H; Bauer HC; Solca F; Hauser-Kronberger C; Ermilov AN; Verhaegen ME; Bichakjian CK; Dlugosz AA; Nietfeld W; Sibilia M; Lehrach H; Wierling C; Aberger F
EMBO Mol Med; 2012 Mar; 4(3):218-33. PubMed ID: 22294553
[TBL] [Abstract][Full Text] [Related]
20. Endothelin-2 is upregulated in basal cell carcinoma under control of Hedgehog signaling pathway.
Tanese K; Fukuma M; Ishiko A; Sakamoto M
Biochem Biophys Res Commun; 2010 Jan; 391(1):486-91. PubMed ID: 19914214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
